NovoLog PenFill and Ranibizumab Intraocular
Determining the interaction of NovoLog PenFill and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Ranibizumab ophthalmic
- NovoLog PenFill-Ranitidine
- NovoLog PenFill-Ranitidine Capsule
- NovoLog PenFill-Ranitidine Hydrochloride
- NovoLog PenFill-Ranitidine Injection
- NovoLog PenFill-Ranitidine Suspension
- Ranibizumab Intraocular-Novoseven
- Ranibizumab Intraocular-NovoSeven RT
- Ranibizumab Intraocular-NovoSeven RT with MixPro injection
- Ranibizumab Intraocular-Novothyrox
- Ranibizumab Intraocular-Noxafil
- Ranibizumab Intraocular-Noxafil (Posaconazole Delayed-Release Tablets)